Rang	Name	Position
1	Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.	President, CEO & Director
2	Mr. Thomas Patrick Kelly J.D.	Chief Financial Officer
3	Ms. Andrea DiFabio J.D.	Chief Legal Officer & Corporate Secretary
4	Dr. Christopher John Kenney M.D.	Chief Medical Officer
5	Mr. Darren S. Cline M.B.A.	Chief Commercial Officer
6	Dr. Matthew D. Ronsheim Ph.D.	Chief Operating Officer
7	Ms. Shelley McCloskey B.A.	Executive Vice President of Human Resources
8	Dr. Robin P. Sherrington Ph.D.	Executive Vice President of Strategy & Innovation
9	Dr. James R. Empfield Ph.D.	Executive Vice President of Drug Discovery
10	Ms. Colleen Alabiso	Senior Vice President of Corporate Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	FMR Inc	11,17%	0,64 Mrd. USD
2	venBio Select Advisor LLC	5,97%	0,34 Mrd. USD
3	BlackRock Inc	5,82%	0,33 Mrd. USD
4	Driehaus Capital Management LLC	4,64%	0,26 Mrd. USD
5	Polar Capital Holdings PLC	4,55%	0,26 Mrd. USD
6	HHG PLC	4,31%	0,25 Mrd. USD
7	Capital Research & Mgmt Co - Division 3	2,44%	0,14 Mrd. USD
8	JPMorgan Chase & Co	1,99%	0,11 Mrd. USD
9	State Street Corp	1,78%	0,10 Mrd. USD
10	Two Sigma Investments LLC	1,70%	0,10 Mrd. USD
11	Deerfield Management Co	1,67%	0,10 Mrd. USD
12	Affinity Asset Advisors, LLC	1,65%	0,09 Mrd. USD
13	Holocene Advisors, LP	1,57%	0,09 Mrd. USD
14	Westfield Capital Management Company, L.P.	1,56%	0,09 Mrd. USD
15	Wellington Management Company LLP	1,47%	0,08 Mrd. USD
16	AllianceBernstein L.P.	1,45%	0,08 Mrd. USD
17	Citadel Advisors Llc	1,45%	0,08 Mrd. USD
18	BNP Paribas Investment Partners SA	1,39%	0,08 Mrd. USD
19	BRAIDWELL LP	1,38%	0,08 Mrd. USD
20	T. Rowe Price Associates, Inc.	1,37%	0,08 Mrd. USD